Category Archives: BioUtah News
Nelson Labs Launches Verification Program to Help Consumers Identify Properly Tested Masks and Respirators
New Nelson Labs Mark offers transparency and confidence in product testing
IONIQ Sciences submits De Novo application to FDA for IONIQ ProLung Test
Salt Lake City, UT, February 2, 2022 – IONIQ Sciences, Inc. (“IONIQ” or the “Company”) announced today that it has filed a De Novo application with the U.S. Food and Drug Administration (the “FDA”) for its IONIQ ProLung Test™ used for lung cancer. Mr. Jared Bauer, IONIQ Sciences CEO, stated, “Today we submitted our De […]
Fluidx Medical’s Embolic Demonstrates Novel Visibility Advantage
Fluidx Medical Reports Initial Research on First-of-its-Kind Embolic Agent with Intermediate Radiopacity
Biomerics Announces Expansion in Costa Rica With New Plant in Cartago
Biomerics inaugurated its second plant in Costa Rica.
GPX Embolic Device Success in Challenging Tumor Case
Fluidx Medical’s Novel Embolic Device Demonstrates Repeated Success in Treating Complex Tumors
Foldax Appoints Scott Huennekens to Board of Directors
Foldax Appoints Scott Huennekens to Board of Directors
PolarityTE Announces U.S. FDA Approval of IND for Pivotal Phase 3 Study of SkinTE® to Support Chronic Cutaneous Ulcer Indication
PolarityTE, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved its investigational new drug (IND) application for the evaluation of SkinTE for the treatment of chronic cutaneous ulcers.
Co-Diagnostics, Inc. JV CoSara Receives Clearance from Indian Regulators for High-Risk HPV Multiplex Test
Co-Diagnostics, Inc. announced that CoSara Diagnostics Pvt Ltd has received clearance by the Central Drugs Standard Control Organization (“CDSCO”) in India to manufacture and sell its SARAGENE™ Human Papillomavirus High-Risk (HPV-HR) Real-Time PCR test as an in vitro diagnostic (“IVD”)
New Peripheral Vascular Microcatheters Save Procedure Time and Advance Treatment Capabilities
New Peripheral Vascular Microcatheters Save Procedure Time and Advance Treatment Capabilities
Positive Study Results Published for KidneyIntelXTM in Monitoring Patient Response to New Drug Therapy
Positive Study Results Published for KidneyIntelXTM in Monitoring Patient Response to New Drug Therapy
CenExel Clinical Research Acquires Rocky Mountain Movement Disorders Center
Premier Neurology Facility in Colorado Joins the CenExel Centers of Excellence
CenExel Clinical Research Acquires California Neuroscience Research
CenExel Clinical Research, Inc. announced the acquisition of California Neuroscience Research.
